Compare Flex Ltd (FLEX) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flex Ltd vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Flex Ltd trades at $116.02 (market cap $44.09B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: Flex Ltd is far larger — about 25.8× Nuvation Bio Inc. Class A Common Stock's market cap, and Flex Ltd is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Flex Ltd for 3 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| FLEX | NUVB | |
|---|---|---|
Market Cap | $44.09B | $1.71B |
Volume | 3,022,166 | 5,448,712 |
Sector | Technology | Health |
52-Week High | $162.07 | $9.54 |
52-Week Low | $54.51 | $3.41 |
Typical Hold Time | 3 Days | 0 Days |
Enterprise Value | $47.18B | $1.30B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Flex Ltd
Flex provides design, engineering, manufacturing, supply chain, and logistics services for technology products. It serves industries including cloud, data centers, communications, automotive, healthcare, and industrials.
Read more on FLEX →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
